Joerg Ermann

7.0k total citations · 3 hit papers
63 papers, 4.9k citations indexed

About

Joerg Ermann is a scholar working on Immunology, Rheumatology and Hematology. According to data from OpenAlex, Joerg Ermann has authored 63 papers receiving a total of 4.9k indexed citations (citations by other indexed papers that have themselves been cited), including 37 papers in Immunology, 31 papers in Rheumatology and 17 papers in Hematology. Recurrent topics in Joerg Ermann's work include Spondyloarthritis Studies and Treatments (23 papers), T-cell and B-cell Immunology (17 papers) and Immune Cell Function and Interaction (16 papers). Joerg Ermann is often cited by papers focused on Spondyloarthritis Studies and Treatments (23 papers), T-cell and B-cell Immunology (17 papers) and Immune Cell Function and Interaction (16 papers). Joerg Ermann collaborates with scholars based in United States, United Kingdom and Germany. Joerg Ermann's co-authors include Samuel Strober, C. Garrison Fathman, Matthias Edinger, Petra Hoffmann, C. Garrison Fathman, Robert S. Negrin, Cariel Taylor, Claire Holness, Suparna Dutt and Jonathan N. Glickman and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Nature Medicine and Nature Communications.

In The Last Decade

Joerg Ermann

60 papers receiving 4.8k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

CD4+CD25+ regulatory T cells preserve graft-versus-tumor activity while inhibiting graft-versus-host disease after bone marrow transplantation

2003 1.0k citations Joerg Ermann, C. Garrison Fathman et al. profile →
Donor-type CD4+CD25+ Regulatory T Cells Suppress Lethal Acute Graft-Versus-Host Disease after Allogeneic Bone Marrow Transplantation

2002 894 citations Joerg Ermann, C. Garrison Fathman et al. profile →
An inflammation-targeting hydrogel for local drug delivery in inflammatory bowel disease

2015 360 citations Joerg Ermann et al. Science Translational Medicine profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Joerg Ermann United States	27	3.0k	1.5k	881	646	620	63	4.9k
Segundo González Spain	44	3.5k 1.2×	648 0.4×	845 1.0×	1.6k 2.4×	869 1.4×	109	5.2k
Luís Graça Portugal	38	4.0k 1.3×	396 0.3×	758 0.9×	686 1.1×	353 0.6×	115	5.4k
Toshio Heike Japan	32	2.6k 0.9×	611 0.4×	1.3k 1.5×	1.5k 2.3×	182 0.3×	167	5.2k
Ansgar Schulz Germany	33	1.7k 0.6×	1.1k 0.8×	1.7k 2.0×	986 1.5×	214 0.3×	122	4.5k
Bonnie Lyons United States	21	1.7k 0.5×	909 0.6×	1.3k 1.5×	1.1k 1.8×	130 0.2×	42	4.1k
Iannis E. Adamopoulos United States	32	1.5k 0.5×	400 0.3×	1.1k 1.2×	566 0.9×	972 1.6×	75	3.3k
Lawrence G. Lum United States	39	2.2k 0.7×	971 0.7×	1.0k 1.2×	1.9k 3.0×	130 0.2×	212	4.7k
Henrik E. Mei Germany	31	2.1k 0.7×	330 0.2×	716 0.8×	374 0.6×	733 1.2×	56	3.7k
Ilan Bank Israel	28	1.9k 0.6×	407 0.3×	613 0.7×	548 0.8×	377 0.6×	81	3.6k
Margaret L. Hibbs Australia	49	4.3k 1.4×	851 0.6×	2.8k 3.2×	1.3k 2.1×	583 0.9×	128	8.2k

Countries citing papers authored by Joerg Ermann

Since Specialization

Citations

This map shows the geographic impact of Joerg Ermann's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Joerg Ermann with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Joerg Ermann more than expected).

Fields of papers citing papers by Joerg Ermann

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Joerg Ermann. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Joerg Ermann. The network helps show where Joerg Ermann may publish in the future.

Co-authorship network of co-authors of Joerg Ermann

This figure shows the co-authorship network connecting the top 25 collaborators of Joerg Ermann. A scholar is included among the top collaborators of Joerg Ermann based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Joerg Ermann. Joerg Ermann is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Ermann, Joerg, et al.. (2024). Reporting of Facet Joint Inflammation in Lumbar Spine MRI Studies in Patients With Low Back Pain. Spine. 49(10). 733–740.

Ermann, Joerg, et al.. (2024). Axial Spondyloarthritis Treatment Recommendations and Disease Activity Monitoring in Clinical Practice: Results of an Online Survey. The Journal of Rheumatology. 51(5). 472–478. 2 indexed citations

Mandell, Jacob, et al.. (2023). Predictors of Outcomes After Lumbar Intra-Articular Facet Joint Injections and Medial Branch Blocks. Spine. 48(20). 1455–1463. 2 indexed citations

McDermott, Gregory C, et al.. (2023). Factors Associated With Diagnostic Delay in Axial Spondyloarthritis: Impact of Clinical Factors and Social Vulnerability. Arthritis Care & Research. 76(4). 541–549. 3 indexed citations

Deodhar, Atul, Denis Poddubnyy, Proton Rahman, et al.. (2023). Long-Term Safety and Efficacy of Ixekizumab in Patients With Axial Spondyloarthritis: 3-year Data From the COAST Program. The Journal of Rheumatology. 50(8). 1020–1028. 7 indexed citations

Proft, Fabian, Désirée van der Heijde, Xenofon Baraliakos, et al.. (2023). POS1104 BIMEKIZUMAB MAINTAINED STRINGENT CLINICAL RESPONSES THROUGH WEEK 52 IN PATIENTS WITH AXIAL SPONDYLOARTHRITIS: RESULTS FROM THE PHASE 3 STUDIES BE MOBILE 1 AND BE MOBILE 2. Annals of the Rheumatic Diseases. 82. 874–875. 2 indexed citations

Navarro‐Compán, Victoria, Joerg Ermann, & Denis Poddubnyy. (2022). A glance into the future of diagnosis and treatment of spondyloarthritis. Therapeutic Advances in Musculoskeletal Disease. 14. 1759720X221111611–1759720X221111611. 15 indexed citations

Schwartzman, Monica, Joerg Ermann, Kristine A. Kuhn, Sergio Schwartzman, & Michael H. Weisman. (2022). Spondyloarthritis in inflammatory bowel disease cohorts: systematic literature review and critical appraisal of study designs. RMD Open. 8(1). e001777–e001777. 20 indexed citations

Tsang, Kelly, Haoming Liu, Yen Kuang Yang, Julia F. Charles, & Joerg Ermann. (2019). Defective circadian control in mesenchymal cells reduces adult bone mass in mice by promoting osteoclast function. Bone. 121. 172–180. 21 indexed citations

10.

Dougados, Maxime, James Cheng‐Chung Wei, Robert Landewé, et al.. (2019). Efficacy and safety of ixekizumab through 52 weeks in two phase 3, randomised, controlled clinical trials in patients with active radiographic axial spondyloarthritis (COAST-V and COAST-W). Annals of the Rheumatic Diseases. 79(2). 176–185. 86 indexed citations

11.

Ryzhakov, Grigory, Nathaniel R. West, Fanny Franchini, et al.. (2018). Alpha kinase 1 controls intestinal inflammation by suppressing the IL-12/Th1 axis. Nature Communications. 9(1). 3797–3797. 43 indexed citations

12.

Sun, Jun, Joerg Ermann, Ningning Niu, et al.. (2018). Histone demethylase LSD1 regulates bone mass by controlling WNT7B and BMP2 signaling in osteoblasts. Bone Research. 6(1). 14–14. 48 indexed citations

13.

Fonseka, Chamith Y., Deepak A. Rao, Nikola C. Teslovich, et al.. (2018). Mixed-effects association of single cells identifies an expanded effector CD4 ⁺ T cell subset in rheumatoid arthritis. Science Translational Medicine. 10(463). 99 indexed citations

14.

Dey, Devaveena, Jana Bagarova, Sarah Hatsell, et al.. (2016). Two tissue-resident progenitor lineages drive distinct phenotypes of heterotopic ossification. Science Translational Medicine. 8(366). 366ra163–366ra163. 153 indexed citations

15.

Charles, Julia F., Joerg Ermann, & Antonios O. Aliprantis. (2015). The intestinal microbiome and skeletal fitness: Connecting bugs and bones. Clinical Immunology. 159(2). 163–169. 55 indexed citations

16.

Dutt, Suparna, Diane Tseng, Joerg Ermann, et al.. (2007). Naive and Memory T Cells Induce Different Types of Graft-versus-Host Disease. The Journal of Immunology. 179(10). 6547–6554. 89 indexed citations

17.

Dutt, Suparna, Diane Tseng, Joerg Ermann, et al.. (2005). Memory CD4 T Cells Induce Graft Versus Host Disease.. Blood. 106(11). 1309–1309. 3 indexed citations

18.

Su, Leon, Rémi J. Creusot, Elena Gallo, et al.. (2004). Murine CD4+CD25+ Regulatory T Cells Fail to Undergo Chromatin Remodeling Across the Proximal Promoter Region of the IL-2 Gene. The Journal of Immunology. 173(8). 4994–5001. 55 indexed citations

19.

Ermann, Joerg, et al.. (2002). The Subpopulation of CD4+CD25+ Splenocytes That Delays Adoptive Transfer of Diabetes Expresses L-Selectin and High Levels of CCR7. The Journal of Immunology. 169(5). 2461–2465. 310 indexed citations

20.

Ermann, Joerg, et al.. (2001). CD4+CD25+ T Cells Facilitate the Induction of T Cell Anergy. The Journal of Immunology. 167(8). 4271–4275. 116 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact